Biological Effects and Use of PrPSc- and PrP-Specific Antibodies Generated by Immunization with Purified Full-Length Native Mouse Prions

被引:25
作者
Petsch, Benjamin [1 ]
Mueller-Schiffmann, Andreas [2 ]
Lehle, Anna [1 ]
Zirdum, Elizabeta [1 ]
Prikulis, Ingrid [2 ]
Kuhn, Franziska [3 ]
Raeber, Alex J. [3 ]
Ironside, James W. [4 ]
Korth, Carsten [2 ]
Stitz, Lothar [1 ]
机构
[1] Friedrich Loeffler Inst, Inst Immunol, Tubingen, Germany
[2] Univ Dusseldorf, Dept Neuropathol, Dusseldorf, Germany
[3] Prion AG, Schlieren, Switzerland
[4] Univ Edinburgh, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh, Midlothian, Scotland
基金
英国医学研究理事会;
关键词
MONOCLONAL-ANTIBODIES; SCRAPIE PRION; PROTEIN PRP; KNOCKOUT MICE; CELLULAR PRP; NUCLEIC-ACID; REPLICATION; DISEASE; EPITOPE; CELLS;
D O I
10.1128/JVI.02467-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The prion agent is the infectious particle causing spongiform encephalopathies in animals and humans and is thought to consist of an altered conformation (PrPSc) of the normal and ubiquitous prion protein PrPC. The interaction of the prion agent with the immune system, particularly the humoral immune response, has remained unresolved. Here we investigated the immunogenicity of full-length native and infectious prions, as well as the specific biological effects of the resulting monoclonal antibodies (MAbs) on the binding and clearance of prions in cell culture and in in vivo therapy. Immunization of prion knockout (Prnp(0/0)) mice with phosphotungstic acid-purified mouse prions resulted in PrP-specific monoclonal antibodies with binding specificities selective for PrPSc or for both PrPC and PrPSc. PrPSc-specific MAb W261, of the IgG1 isotype, reacted with prions from mice, sheep with scrapie, deer with chronic wasting disease (CWD), and humans with sporadic and variant Creutzfeldt-Jakob disease (CJD) in assays including a capture enzyme-linked immunosorbent assay (ELISA) system. This PrPSc-specific antibody was unable to clear prions from mouse neuroblastoma cells (ScN2a) permanently infected with scrapie, whereas the high-affinity MAb W226, recognizing both isoforms, PrPSc and PrPC, did clear prions from ScN2a cells, as determined by a bioassay. However, an attempt to treat intraperitoneally prion infected mice with full-length W226 or with a recombinant variable-chain fragment (scFv) from W226 could only slightly delay the incubation time. We conclude that (i) native, full-length PrPSc elicits a prion-specific antibody response in PrP knockout mice, (ii) a PrPSc-specific antibody had no prion-clearing effect, and (iii) even a high-affinity MAb that clears prions in vitro (W226) may not necessarily protect against prion infection, contrary to previous reports using different antibodies.
引用
收藏
页码:4538 / 4546
页数:9
相关论文
共 46 条
  • [1] Protein aggregation diseases: pathogenicity and therapeutic perspectives
    Aguzzi, Adriano
    O'Connor, Tracy
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (03) : 237 - 248
  • [2] Generation of antibodies against prion protein in wild-type mice via helix 1 peptide immunization
    Arbel, M
    Lavie, V
    Solomon, B
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2003, 144 (1-2) : 38 - 45
  • [3] Neutralizing antiviral B cell responses
    Bachmann, MF
    Zinkernagel, RM
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 235 - 270
  • [4] T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: Role of antigen patterns in B cell induction?
    Bachmann, MF
    Hengartner, H
    Zinkernagel, RM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (12) : 3445 - 3451
  • [5] SCRAPIE AND CELLULAR PRP ISOFORMS ARE ENCODED BY THE SAME CHROMOSOMAL GENE
    BASLER, K
    OESCH, B
    SCOTT, M
    WESTAWAY, D
    WALCHLI, M
    GROTH, DF
    MCKINLEY, MP
    PRUSINER, SB
    WEISSMANN, C
    [J]. CELL, 1986, 46 (03) : 417 - 428
  • [6] PrPSc binding antibodies are potent inhibitors of prion replication in cell lines
    Beringue, V
    Vilette, D
    Mallinson, G
    Archer, F
    Kaisar, M
    Tayebi, M
    Jackson, GS
    Clarke, AR
    Laude, H
    Collinge, J
    Hawke, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (38) : 39671 - 39676
  • [7] Non-infectious aggregates of the prion protein react with several PrPSc-directed antibodies
    Biasini, E.
    Seegulam, M. E.
    Patti, B. N.
    Solforosi, L.
    Medrano, A. Z.
    Christensen, H. M.
    Senatore, A.
    Chiesa, R.
    Williamson, R. A.
    Harris, D. A.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2008, 105 (06) : 2190 - 2204
  • [8] IDENTIFICATION OF A PROTEIN THAT PURIFIES WITH THE SCRAPIE PRION
    BOLTON, DC
    MCKINLEY, MP
    PRUSINER, SB
    [J]. SCIENCE, 1982, 218 (4579) : 1309 - 1311
  • [9] Cultured cell sublines highly susceptible to prion infection
    Bosque, PJ
    Prusiner, SB
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (09) : 4377 - 4386
  • [10] NORMAL DEVELOPMENT AND BEHAVIOR OF MICE LACKING THE NEURONAL CELL-SURFACE PRP PROTEIN
    BUELER, H
    FISCHER, M
    LANG, Y
    BLUETHMANN, H
    LIPP, HP
    DEARMOND, SJ
    PRUSINER, SB
    AGUET, M
    WEISSMANN, C
    [J]. NATURE, 1992, 356 (6370) : 577 - 582